Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?
JAMA Network Open · 03.11.2026 · 9 (11) · e2640988
DOI: 10.1001/jamanetworkopen.2026.40988 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 03.11.2026. Verfasst von Karla Hemming und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
- Statistical Editor, JAMA Network Open.
- Department of Medicine, University of Washington, Seattle.
- Executive Deputy Director, JAMA Network Open.
Zitieren
APA
Hemming, K., & Fihn, S. D. (2026). Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?. JAMA Network Open, 9(11), e2640988. https://doi.org/10.1001/jamanetworkopen.2026.40988
Vancouver
Hemming K, Fihn SD. Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?. JAMA Network Open. 2026;9(11):e2640988. doi:10.1001/jamanetworkopen.2026.40988
BibTeX
@article{Hemming2026,
author = {Hemming, Karla and Fihn, Stephan D},
title = {Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {11},
pages = {e2640988},
doi = {10.1001/jamanetworkopen.2026.40988}
}
EUVIMED